Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

114 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Corrigendum: Examination of critical factors influencing ruminant disease dynamics in the Black Sea Basin.
Arede M, Beltrán-Alcrudo D, Aliyev J, Chaligava T, Keskin I, Markosyan T, Morozov D, Oste S, Pavlenko A, Ponea M, Starciuc N, Zdravkova A, Raizman E, Casal J, Allepuz A. Arede M, et al. Among authors: allepuz a. Front Vet Sci. 2024 Feb 28;11:1376956. doi: 10.3389/fvets.2024.1376956. eCollection 2024. Front Vet Sci. 2024. PMID: 38482166 Free PMC article.
Examination of critical factors influencing ruminant disease dynamics in the Black Sea Basin.
Arede M, Beltrán-Alcrudo D, Aliyev J, Chaligava T, Keskin I, Markosyan T, Morozov D, Oste S, Pavlenko A, Ponea M, Starciuc N, Zdravkova A, Raizman E, Casal J, Allepuz A. Arede M, et al. Among authors: allepuz a. Front Vet Sci. 2023 Sep 22;10:1174560. doi: 10.3389/fvets.2023.1174560. eCollection 2023. Front Vet Sci. 2023. PMID: 37808108 Free PMC article.
Health-related quality of life of patients with resistant/intolerant chronic phase chronic myeloid leukemia treated with asciminib or bosutinib in the phase 3 ASCEMBL trial.
Réa D, Boquimpani C, Mauro MJ, Minami Y, Allepuz A, Maheshwari VK, D'Alessio D, Wu Y, Lawrance R, Narbutas S, Sharf G, Hochhaus A. Réa D, et al. Among authors: allepuz a. Leukemia. 2023 May;37(5):1060-1067. doi: 10.1038/s41375-023-01888-y. Epub 2023 Apr 14. Leukemia. 2023. PMID: 37069326 Free PMC article. Clinical Trial.
Asciminib vs bosutinib in chronic-phase chronic myeloid leukemia previously treated with at least two tyrosine kinase inhibitors: longer-term follow-up of ASCEMBL.
Hochhaus A, Réa D, Boquimpani C, Minami Y, Cortes JE, Hughes TP, Apperley JF, Lomaia E, Voloshin S, Turkina A, Kim DW, Abdo A, Fogliatto LM, le Coutre P, Sasaki K, Kim DDH, Saussele S, Annunziata M, Chaudhri N, Chee L, García-Gutiérrez V, Kapoor S, Allepuz A, Quenet S, Bédoucha V, Mauro MJ. Hochhaus A, et al. Among authors: allepuz a. Leukemia. 2023 Mar;37(3):617-626. doi: 10.1038/s41375-023-01829-9. Epub 2023 Jan 30. Leukemia. 2023. PMID: 36717654 Free PMC article. Clinical Trial.
114 results